Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Study: PrEP Adherence Curbs HIV Transmission in Straight Couples in Uganda

September 17, 2013

A study of HIV-negative heterosexuals who followed instructions for pre-exposure prophylaxis (PrEP) therapy indicated that PrEP was successful in preventing HIV. The researchers studied 1,147 HIV-negative individuals in long-term stable heterosexual relationships (average length of relationship was 8.5 years) with HIV-infected partners. Participants were from three Ugandan sites of the Partners PrEP study, which provided them with either Viread (tenofovir) or Truvada (tenofovir/emtricitabine). The group had six months of follow up left in the trial, had a median age of 34 years, and was 53 percent male.

View Full Article


  
  • Email Email
  • Comments Comments
  •  (1)
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 
See Also
More News and Research on HIV Medications for HIV Prevention

Reader Comments:

Comment by: michael (los angeles) Mon., Sep. 23, 2013 at 7:53 am EDT
great news....but all for not if the cost for one bottle of truvada remains at $900 per bottle....gotta love patents on life saving medicine for the sake of profit.
Reply to this comment


Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement